Literature DB >> 4309138

Rapidly labeled cytoplasmic RNA in normal and phytohaemagglutinin-stimulated human lymphocytes.

J E Kay, H L Cooper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4309138     DOI： 10.1016/0005-2787(69)90490-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN： 0006-3002


× No keyword cloud information.
  7 in total

1.  [A study of nucleic acids and protein metabolism during the first six days of the cephalic regeneration of Eisenia foetida (Sav.)].

Authors:  Henri Lechenault; Marie Gontcharoff
Journal:  Wilhelm Roux Arch Entwickl Mech Org       Date:  1973-03

2.  [Studies of nucleic acids and protein metabolism during initiation of adventitious roots].

Authors:  R Jalouzot
Journal:  Planta       Date:  1971-03       Impact factor: 4.116

3.  The early uptake of radioactive calcium by human lymphocytes treated with phytohaemagglutinin.

Authors:  G Allwood; G L Asherson; M J Davey; P J Goodford
Journal:  Immunology       Date:  1971-09       Impact factor: 7.397

Review 4.  Cellular and molecular aspects of immune system aging.

Authors:  D L Doggett; M P Chang; T Makinodan; B L Strehler
Journal:  Mol Cell Biochem       Date:  1981-07       Impact factor: 3.396

5.  Cyclic adenosine 3',5'-monophosphate in human lymphocytes. Alterations after phytohemagglutinin stimulation.

Authors:  J W Smith; A L Steiner; W M Newberry; C W Parker
Journal:  J Clin Invest       Date:  1971-02       Impact factor: 14.808

6.  Biosynthesis of transfer RNA: in vitro conversion of transfer RNA precursors from Bombyx mori to 4S RNA by Escherichia coli enzymes.

Authors:  G S Chen; M A Siddiqui
Journal:  Proc Natl Acad Sci U S A       Date:  1973-09       Impact factor: 11.205

7.  Inhibition of phytohaemagglutinin-induced autorosette formation of human peripheral blood lymphocytes by RNA or protein synthesis inhibitor.

Authors:  S Hyodo; T Kishi; E Kittaka; T Suzawa; A Tanabe; Y Tanaka; T Sakano; T Usui
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.